Kesmodel, S., Ellis, L., Lin, E., Chang, G., Abdalla, E., Kopetz, S., . . . Feig, B. (2008). Preoperative Bevacizumab Does Not Significantly Increase Postoperative Complication Rates in Patients Undergoing Hepatic Surgery for Colorectal Cancer Liver Metastases.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)Kesmodel, Susan, et al. Preoperative Bevacizumab Does Not Significantly Increase Postoperative Complication Rates in Patients Undergoing Hepatic Surgery for Colorectal Cancer Liver Metastases. 2008.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)Kesmodel, Susan, et al. Preoperative Bevacizumab Does Not Significantly Increase Postoperative Complication Rates in Patients Undergoing Hepatic Surgery for Colorectal Cancer Liver Metastases. 2008.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.